Company News
Schott researcher receives Turner Award
Schott researcher receives Turner Award
Professor Volker Rupertus is honoured for his involvement in the International Commission on Glass
Abzena hires Dr Campbell Bunce to new role of SVP Scientific Operations
Abzena hires Dr Campbell Bunce to new role of SVP Scientific Operations
Adds further immunology expertise to the Executive Management Team
Auspherix appoints Dr Neil Miller as Chief Scientific Officer
Auspherix appoints Dr Neil Miller as Chief Scientific Officer
He spent two decades in the pharmaceutical industry at GlaxoSmithKline
Catherine Turkel joins OticPharma as Chief Development Officer
Catherine Turkel joins OticPharma as Chief Development Officer
Will lead the firm's preclinical, clinical, regulatory and CMC functions in the US
Dr Robert Zeldin takes over as Chief Medical Officer at Ablynx
Dr Robert Zeldin takes over as Chief Medical Officer at Ablynx
He will lead the company's global clinical development, regulatory and medical affairs activities
Innophos appoints Kim Ann Mink as Chief Executive
Innophos appoints Kim Ann Mink as Chief Executive
Current CEO Randy Gress plans to retire
Professor Michael Linden to head Pfizer's new gene therapy research centre in London
Professor Michael Linden to head Pfizer's new gene therapy research centre in London
Expert from King's College London has spent more than two decades researching use of adeno-associated viruses to transport medicines into the body
Goplasticpallets.com doubles sales team in six months
Goplasticpallets.com doubles sales team in six months
The plastic pallets specialist has doubled its salesforce in the last six months
Professor Alan Boyd elected as President of the Faculty of Pharmaceutical Medicine
Professor Alan Boyd elected as President of the Faculty of Pharmaceutical Medicine
He has succeeded Dr Keith Bragman
Celsion names Edwin De Wit as Senior Vice President and Head of Medical, Europe
Celsion names Edwin De Wit as Senior Vice President and Head of Medical, Europe
Establishes a European subsidiary to support clinical studies and early access programmes
Steve Turley joins UCB as Managing Director for UK and Ireland
Steve Turley joins UCB as Managing Director for UK and Ireland
He will also become a member of UCB's European Leadership Team
Guido Rasi takes office as head of EMA
Guido Rasi takes office as head of EMA
Executive Director appointed for five-year term
F-star expands management team
F-star expands management team
Appoints Dr Neil Brewis as Chief Scientific Officer
ClinTec celebrates further global expansion
ClinTec celebrates further global expansion
And long service awards in clinical excellence with the Lord Provost of Glasgow
Vaccinogen promotes Peter Morsing to Chief Operating Officer
Vaccinogen promotes Peter Morsing to Chief Operating Officer
Will lead the cancer vaccine company's clinical, logistical, manufacturing and business development activities
High Force Research takes on its first apprentice chemist
High Force Research takes on its first apprentice chemist
Megan Jones will also study part-time for a chemistry degree at Teesside University
Medica Packaging makes a promotion
Medica Packaging makes a promotion
Amanda Bailey become Sales Manager at the manufacturer of printed folding cartons and leaflets for the pharmaceutical and healthcare industries
Symbiosis hires new Business Development Manager
Symbiosis hires new Business Development Manager
Promotes Joanne Anderson to the role after three years with the company
JHL Biotech appoints new leaders to management team
JHL Biotech appoints new leaders to management team
Four new people step into financial, manufacturing, R&D and engineering roles
Martin Mercer becomes President of Lupin's Latin American business
Martin Mercer becomes President of Lupin's Latin American business
He also takes responsibility for its overall strategy for generics and speciality business in Brazil, Mexico, Venezuela, Colombia and Argentina
Laszlo Radvanyi joins Merck as Head of Global Immuno-Oncology Research
Laszlo Radvanyi joins Merck as Head of Global Immuno-Oncology Research
Radvanyi brings more than 25 years of experience in immuno-oncology R&D to the firm
Rx-360 announces Mark Paxton as its first CEO
Rx-360 announces Mark Paxton as its first CEO
Acknowledges successful growth of the supply chain organisation over the past six years
Crown Bioscience hires two industry veterans for expansion in Asia-Pacific
Crown Bioscience hires two industry veterans for expansion in Asia-Pacific
To lead business development in Japan and Australia, Singapore, New Zealand and Korea
Nabriva Therapeutics appoints Will Sargent as Vice President of Commercial Strategy and Investor Relations
Nabriva Therapeutics appoints Will Sargent as Vice President of Commercial Strategy and Investor Relations
He will lead development of commercial strategy for the launch of lefamulin for the treatment of community-acquired bacterial pneumonia (CABP)